Abstract
Circulating tumor DNA is a liquid biomarker that offers a highly specific method to assess HPV-associated tumor burden via a blood draw. It has the potential for many clinical applications in cancer care, including prognostication, monitoring treatment response, and surveillance for disease recurrence. In this case report, we present a case of recurrent HPV-associated hypopharyngeal squamous cell carcinoma first detected by circulating tumor HPV DNA that demonstrates the role of circulating tumor HPV DNA tests in posttreatment surveillance and the utility of HPV testing in all HPV-mediated tumors, regardless of subsite.
Original language | English |
---|---|
Article number | 100537 |
Journal | Otolaryngology Case Reports |
Volume | 27 |
DOIs | |
State | Published - Jun 2023 |
Keywords
- Circulating tumor DNA
- Head and neck cancer
- Human papillomavirus